recommended risk stratification strategy for osteoporosis therapy
- Low/Moderate-risk patients
- Oral bisphosphonates (alendronate, risedronate, ibandronate)
- Zoledronic acid
- Denosumab
- High-risk patients aa High-risk patients: old age, prior fracture, very low BMD (T-score <–3), high fall risk, GC use.
- Zoledronic acid
- Denosumab
- Teriparatide
- Abaloparatide
